Biomatlante

our mission: develop and promote mbcp™ proprietary synthetic technology as the scaffold of reference in any bone regeneration solution for best-in-class patient care. our vision bone surgeries often demand grafts for which autograft is considered as the gold standard in terms of tissue regeneration performance and limited rejection risk. autograft is available in limited quantity though, and harvesting methods are expensive and above all invasive with secondary effects which are often complex to solve. our synthetic bone grafts solutions have been demonstrating performances which are close to autograft, with no associated complications, no limits in quantity and are cost effective. micro/macroporous properties of biomatlante products allow us to claim the largest specific surface of adsorption on the bioceramic market. this leads to an optimum osteogenecity in any bone regeneration procedure. these properties also make mbcp™ proprietary technology the ideal scaffold for any bone tissue